May 2018

AKT Inhibitor May Overcome Chemotherapy Resistance in TNBC

May 26, 2018

Clinical Trials in Progress

A novel inhibitor that targets the AKT node in the PI3K pathway may offer a treatment option for patients with triple-negative breast cancer (TNBC) who are resistant to chemotherapy.

Novel Combo Explored for Rare Brain Tumor

May 16, 2018

Clinical Trials in Progress

Clinical Trial in Progress: Investigators are seeking to determine whether the combination of eflornithine with lomustine can improve survival for patients with recurrent anaplastic astrocytoma, a rare form of brain tumor.

Bioimpedance Spectroscopy Can Help Prevent Clinical Lymphedema

May 12, 2018

Adverse Events Report

Several breast cancer treatment programs are reporting substantially less clinical lymphedema, particularly among patients at high risk after axillary dissection, radiation, or taxane-based chemotherapy, crediting their use of preclinical detection using bioimpedance spectroscopy (BIS).